Status:
ACTIVE_NOT_RECRUITING
Effectiveness of a Digital Health Application for Psoriasis
Lead Sponsor:
Gaia AG
Collaborating Sponsors:
University of Giessen
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Psoriasis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial with 348 patients with psoriasis aims to investigate the effectiveness of a self-guided online program for patients with psoriasis. Patients will be randomized and allocated in a ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Presence of psoriasis vulgaris or psoriatic arthritis
- Submission of a specialist medical certificate attesting to the presence of at least one of the following ICD-10-GM diagnoses: Psoriasis vulgaris (L 40.0, L 40.7), Psoriatic arthritis (L40.5, M07.x)
- Impaired health-related quality of life (DLQI \> 10)
- Consent to participate
- Sufficient understanding of the German language
Exclusion
- Presence of another subtype of psoriasis (pustular psoriasis, guttate psoriasis, inverse psoriasis, erythrodermic psoriasis, or drug-induced psoriasis) or psoriatic arthritis without skin involvement
- Presence of malignancies
- Presence of other chronic diseases with strong negative influence on quality of life
- Currently undergoing psychiatric treatment / current presence of a severe psychiatric diagnosis
- Insufficient language and/or IT skills
Key Trial Info
Start Date :
September 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
348 Patients enrolled
Trial Details
Trial ID
NCT06027034
Start Date
September 4 2023
End Date
December 1 2026
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GAIA AG
Hamburg, Hamburg, Germany, 22085